Name: UMIN ID:
Unique ID issued by UMIN | UMIN000015949 |
---|---|
Receipt number | R000018280 |
Scientific Title | A Prospective, Multi-center Phase II Trial on the Efficacy and Safety of Low-dose Erlotinib Monotherapy for Frail Patients with EGFR Mutation-positive, Non-small Cell Lung Cancer(TORG1425) |
Date of disclosure of the study information | 2014/12/15 |
Last modified on | 2020/05/15 14:48:14 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2014/12/15 13:55:08 | ||
2 | Update | 2014/12/15 14:00:21 | Email |
|
3 | Update | 2014/12/17 10:50:38 | Anticipated trial start date |
|
4 | Update | 2016/05/19 13:27:45 | Name of primary person or sponsor Organization Organization Organization |
|
5 | Update | 2016/05/19 13:30:18 | Organization Organization |
|
6 | Update | 2016/05/19 13:32:20 | Organization |
|
7 | Update | 2017/12/11 09:25:55 | Recruitment status |
|
8 | Update | 2018/06/19 09:17:35 | Last follow-up date |
|
9 | Update | 2019/04/24 09:30:22 | Recruitment status Date of IRB Anticipated trial start date |
|
10 | Update | 2020/05/15 14:43:09 | URL releasing protocol Publication of results URL related to results and publications Number of participants that the trial has enrolled Results Results Results date posted Date of the first journal publication of results Baseline Characteristics Baseline Characteristics Participant flow Participant flow Adverse events Adverse events Outcome measures Outcome measures |
|
11 | Update | 2020/05/15 14:48:14 | URL related to results and publications |